ArticleBMC neurology2026
Total Cholesterol, High-Density Lipoprotein, and Glucose (CHG) index and risk of stroke in middle-aged and elderly Chinese adults: a nationwide prospective cohort study.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Association Between Cholesterol-HDL-Glucose Index and Stroke Risk in Middle-Aged and Elderly Adults Without Diabetes: Evidence From Two National Cohort Studies.Cardiology research · 2026Article
- Associations of cumulative exposure and dynamic trajectories of the cholesterol-HDL-glucose index and its obesity-related derivatives with cardiovascular disease: a nationwide prospective cohort study.Cardiovascular diabetology · 2026Article
- The cholesterol, high-density lipoprotein, and glucose index and its derived indices predict diabetic kidney disease development and progression: evidence from two nationwide cohorts and a biopsy-proven clinical cohort.Cardiovascular diabetology · 2026Article
- Cholesterol, high-density lipoprotein, and glucose (CHG) index and incident impaired fasting glucose in Chinese adults: a retrospective longitudinal cohort study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCurrent literature lacks reliable evidence on the association between Total Cholesterol, High-Density Lipoprotein, and Glucose (CHG) and stroke incidence. Therefore, this study aims to investigate the potential association between CHG and stroke risk in a middle-aged and elderly Chinese population.
methodsThis is a prospective cohort study, and the data is derived from the China Health and Retirement Longitudinal Study. Cox proportional hazards regression models were utilized to explore relationships between CHG and stroke incidence. To identify potential nonlinear relationships, Cox proportional hazards regression models with restricted cubic spline functions were constructed. Additionally, Receiver Operating Characteristic (ROC) curves were developed to explore the predictive ability of CHG for stroke.
resultsThis study included a total of 10,396 participants, with female accounting for 53.27%. Through five survey cycles from 2011 to 2020, 953 (9.17%) incident strokes occurred. After multivariate adjustment, Cox regression modeling showed that each 1-unit increase in CHG was associated with a 33.5% increased risk of stroke (HR 1.335; 95% CI 1.063–1.677). A nonlinear relationship was identified, with an inflection point at CHG = 4.556. On the left side of that point, each unit increase in CHG was associated with a statistically nonsignificant increase of 12.4% in stroke risk (HR = 1.126; 95% CI: 0.691–1.835), while on the right side of the point, it was linked to a 58.0% increase in risk (HR = 1.580; 95% CI: 1.097–2.274). Additionally, in predicting stroke risk, the AUC value for CHG (0.5737) was higher than that of TyG (0.5679), TC/HDL-c (0.5619), FPG (0.5513), HDL-c (0.5424), and TC (0.5334).
conclusionsThis study found that CHG is positively related to stroke risk and exhibits a non-linear relationship, with a turning point at 4.556. CHG may serve as an early marker for high-risk populations, and proactive monitoring and interventions, including lifestyle changes and management of other metabolic indicators for those with CHG above 4.556, may help lower stroke risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.